-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
August 01, 2014 - Does the use of procalcitonin guidance reduce antibiotic resistance and antibiotic adverse
events? … Outcome measures should consider the consequences of
reduction in antibiotic usage on antibiotic resistance … Adequate statistical methods will be
needed to control for confounders and secular
trends in resistance … Does the use of procalcitonin guidance reduce antibiotic resistance and antibiotic adverse
events? … Vulnerable to antibiotic
resistance and adverse effects
of antibiotics.
-
effectivehealthcare.ahrq.gov/products/osteoarthritis-knee-update/research-2017
May 04, 2017 - Strength and resistance training, pulsed electromagnetic field therapy, and transcutaneous electrical … short-term outcomes of interest include TENS for pain (moderate strength of evidence [SoE]); strength and resistance
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
July 19, 2013 - of antibiotics
has been associated with poorer clinical outcomes and increased incidences of drug
resistance … impairment, may help
improve antibiotic use and associated clinical outcomes and reduce antibiotic resistance … Optimizing drug exposure to minimize selection of antibiotic
resistance. … Antibiotic resistance—what's dosing got to do
with it? Crit Care Med. 2008 Aug;36(8):2433-40. … Pathogens that have resistance to at least two or more of the
antibiotics commonly used to treat them
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
February 10, 2016 - as operationalized in each study, including obstructive sleep apnea and upper airway
resistance … as operationalized in each study, including obstructive sleep
apnea and upper airway resistance … as operationalized in each study, including obstructive sleep apnea and
upper airway resistance … as operationalized in each study, including obstructive sleep apnea and
upper airway resistance … as operationalized in each study, including obstructive sleep apnea and
upper airway resistance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
January 01, 2010 - , adverse events (including
allergic and nonallergic toxicity [e.g., hypotension],
antimicrobial resistance … mortality, adverse events (including
allergic and nonallergic toxicity [e.g., hypotension],
antimicrobial resistance … mortality, adverse events (including
allergic and nonallergic toxicity [e.g., hypotension],
antimicrobial resistance … adverse effects of screening and treatment, including
allergic reactions, nonallergic toxicities, and resistance … screening include decreased room availability, decreased
attention from health care personnel, antibiotic resistance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-protocol-appendix-a.pdf
March 12, 2024 - Appendix A. Search Strategies - Fiber Intake and Laxation Outcomes
Appendix A. Search Strategies
PubMed
Search
number
Query Results
1 "cereal fiber"[tiab:~2] OR "cereal fibers" OR "cereal fibre"[tiab:~2] OR "cereal fibres"OR
((cereal OR edible OR whole) AND grain*) OR "soluble fiber*" OR "soluble fibre*" …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
September 01, 2011 - practice results
from low-intensity treatment or non-adherence – rather than from true
treatment “resistance … the problem of treatment resistance this way offers
the best grasp of the scope of the problem—particularly … as evidence
of the role of other issues in treatment resistance emerge, such as
comorbidity or early … Let me make my overall point by quoting from a book I am editing
entitled Treatment Resistance and Patient … Plakun and Edward R
Shapiro, takes a broad view of the scope of the problem of treatment
resistance
-
effectivehealthcare.ahrq.gov/products/mrsa-screening-2010/research
June 20, 2013 - mortality; adverse events (including allergic and nonallergic toxicity [e.g., hypotension], antimicrobial resistance
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-3rdplace_tympanic.pdf
January 26, 2013 - to manage AOM, but a “wait and see” approach is increasingly used
given concerns about medication resistance … Antibiotic resistance
2. Allergic reactions
3.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_research-protocol.pdf
September 22, 2014 - For example, antibiotic resistance may
be affected by factors other than inappropriate prescribing of … These outcomes have a weak link to health outcomes, including antibiotic
resistance than other intermediate … the patient’s illness severity, or the clinician’s diagnostic certainty, source of
resistance … Key Question 2
• Mortality
• Antibiotic resistance
• Medical complications
• Adverse drug effects … resistance!
! Medical!complications!)e.g.!
Mortality,!Adverse!drug!
effects)!
KQ3:#
! Time!to!
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-protocol.pdf
July 01, 2023 - their effects on the patient microbiome as well as evolutionary
pressure on pathogens leading to drug-resistance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
January 01, 2010 - being reported regarding adverse events such as allergic
reactions, other toxicities and antimicrobial resistance … Would consider adding in more about the concern for development of
mupirocin or chlorhexidine resistance
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - misuse of antibiotics can result in adverse events and add to the
increasing problem of antibiotic resistance … Adverse events: Pain, local bleeding, local infection, persistent or
recurrent infection, antibiotic resistance … Adverse events of
testing and therapy
(e.g., persistent or
recurrent infection,
and antibiotic
resistance … Adverse events of
testing and therapy
(e.g., persistent or
recurrent infection,
and antibiotic
resistance … Source: www.effectivehealthcare.ahrq.gov
Published Online: September 8, 2011
resistance?
II.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
June 01, 2013 - The
context in which screening is implemented (e.g., prior multidrug resistance organism control
programs … and which
outcomes to measure (e.g., the downstream effects of treatment, including
antimicrobial resistance … '/exp OR 'methicillin resistance'
OR
'methicillin'/exp
OR
methicillin AND resistan* AND staphylococcus … in the CCTR
Clinical Trials.Gov
methicillin-resistant staphylococcus aureus
OR
methicillin resistance … NCT Number
Title: Clinical Trial to Reduce
Antibiotic Resistance in
European Intensive Cares
(MOSAR-ICU
-
effectivehealthcare.ahrq.gov/products/mrsa-screening-2010
June 02, 2011 - Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
Timeline
September 07, 2010
Topic Initiated
June 02, 2011
Research Protocol
Archived
Comparative Effectiveness of Screening for Methicillin-Resistant Staphylococcus aureus (MRSA)
June …
-
effectivehealthcare.ahrq.gov/products/treatment-resistant-depression
December 09, 2009 - Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults
Timeline
January 01, 2005
Topic Initiated
December 09, 2009
Research Protocol
Archived
Non-Pharmacologic Interventions for Treatment-resistant Depression in Adults — Research Protoco…
-
effectivehealthcare.ahrq.gov/products/treatment-resistant-depression/research-protocol
December 09, 2009 - Current Page Topic Timeline Jan. 1, 2005 Topic Initiated Dec. 9, 2009 Research Protocol Sep. 23, 2011 Systematic Review Jan. 5, 2012 Disposition of Comments Report May. 3, 2016 Surveillance Report Non-Pharmacologic Interventions for Treatment-resistant Depression in Adults — Research Protocol Document
Research Pro…
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
December 22, 2014 - These new drugs are all costly, and although payers have signaled resistance to the high prices,
and … However, third-party payers have
demonstrated resistance against potentially unsustainable pricing … The sensitivity and specificity of the MTB/RIF test for rifampicin resistance
were 94.4% and 98.3%, … Two-hour detection of MTB
and resistance to rifampicin [0089-01]. … Rapid molecular detection of tuberculosis and
rifampin resistance.
-
effectivehealthcare.ahrq.gov/sites/default/files/web-based_willis_respondent.pdf
January 01, 2009 - cancer
continuum
Slide
3:
Changing
the
Culture
of
Oncology
• Resistance
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - presence of psychotic features (often not identified or diagnosed) is a major reason for
treatment resistance